MISSISSAUGA, ON, April 21, 2014 /CNW/ - Cipher Pharmaceuticals Inc.
(TSX: DND) ("Cipher" or "the Company") today announced it will host a
conference call for its Q1 2014 financial results and hold its Annual
General Meeting of Shareholders on Friday, May 2, 2014.
Q1 2014 CONFERENCE CALL
WHEN: Friday, May 2, 2014 at 8:30AM ET
CONFERENCE CALL/WEBCAST: You can join the call by dialing 647-427-7450
or 1-888-231-8191. A live audio webcast will be available through http://www.cipherpharma.com or http://bit.ly/1eO4nJg. An archived replay of the webcast will be available for 365 days.
ANNUAL GENERAL MEETING OF SHAREHOLDERS
WHEN: Friday, May 2, 2014 at 11:00AM ET
WHERE: Goodmans LLP, Bay Adelaide Centre, 333 Bay Street, Suite 3400,
WEBCAST: The meeting will be webcast live. To access the webcast go to http://www.cipherpharma.com or http://bit.ly/1r2Pcf2. Please connect at least 15 minutes prior to the start of the meeting
to ensure adequate time for any software download that may be required
to join the webcast. An archived replay of the webcast will be
available for 365 days.
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: DND) is a growing specialty pharmaceutical
company with three commercial products and a fourth in development. Our
product candidates are typically improved formulations of successful,
currently marketed drugs. We in-license a product, manage the required
clinical development and regulatory approval process, and either
out-license it to a marketing partner, or, in Canada, we may market the
product ourselves. Our core capabilities are in clinical and regulatory
affairs, product licensing, supply chain management, and marketing and
sales. Since the Company was founded in 2000, we have achieved final
regulatory approval in the U.S. and Canada for all three of our
original products and completed six marketing partnerships, generating
growing licensing revenue.
SOURCE: Cipher Pharmaceuticals Inc.
For further information:
(416) 815-0700 ext 278
(416) 815-0080 fax
Chief Financial Officer
(905) 602-5840 ext 323
(905) 602-0628 fax